BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1764645)

  • 1. Temporary tarsorrhaphy induced with type A botulinum toxin.
    Wuebbolt GE; Drummond G
    Can J Ophthalmol; 1991 Dec; 26(7):383-5. PubMed ID: 1764645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection.
    Naik MN; Gangopadhyay N; Fernandes M; Murthy R; Honavar SG
    Eye (Lond); 2008 Sep; 22(9):1132-6. PubMed ID: 17510652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective ptosis by botulinum A toxin injection in corneal affectations].
    Gusek-Schneider GC; Erbguth F
    Klin Monbl Augenheilkd; 1998 Jul; 213(1):15-22. PubMed ID: 9743934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A-induced protective ptosis in corneal disease.
    Kirkness CM; Adams GG; Dilly PN; Lee JP
    Ophthalmology; 1988 Apr; 95(4):473-80. PubMed ID: 3050691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A induced protective ptosis.
    Adams GG; Kirkness CM; Lee JP
    Eye (Lond); 1987; 1 ( Pt 5)():603-8. PubMed ID: 3446541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis.
    Ellis MF; Daniell M
    Clin Exp Ophthalmol; 2001 Dec; 29(6):394-9. PubMed ID: 11778810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cornea protection in ptosis induced by botulinum injection].
    Brans JW; Aramideh M; Schlingemann RO; Oen VM; Speelman JD; Ongerboer de Visser BW
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1031-3. PubMed ID: 8684496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occlusion therapy of unilateral amblyopia with botulinum toxin induced ptosis.
    Halkiadakis I; Iliaki O; Kalyvianaki MI; Tsilimbaris MK
    Semin Ophthalmol; 2007; 22(1):55-7. PubMed ID: 17366121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of epithelialisation and re-operations in corneal ulcers treated with amniotic membrane transplantation combined with botulinum toxin-induced ptosis.
    Fuchsluger T; Tuerkeli E; Westekemper H; Esser J; Steuhl KP; Meller D
    Graefes Arch Clin Exp Ophthalmol; 2007 Jul; 245(7):955-64. PubMed ID: 17219124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].
    Schilimow A; Wiechens B
    Ophthalmologe; 2017 Aug; 114(8):745-747. PubMed ID: 27766386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficacy and safety of botulinum toxin type A injection in patients requiring temporary tarsorrhaphy to improve corneal epithelial defects.
    Kasaee A; Musavi MR; Tabatabaie SZ; Hashemian MN; Mohebbi S; Khodabandeh A; Rajabi MT
    Int J Ophthalmol; 2010; 3(3):237-40. PubMed ID: 22553562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified transconjunctival technique for botulinum toxin chemodenervation of levator palpebrae superioris for corneal protection.
    Tint NL; Saxby EPI; Young SL; Alexander P
    Eye (Lond); 2022 Jun; 36(6):1217-1221. PubMed ID: 34117397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for temporary corneal protection after surgery for vestibular schwannoma.
    Prell J; Rampp S; Rachinger J; Scheller C; Alfieri A; Marquardt L; Strauss C; Bau V
    J Neurosurg; 2011 Feb; 114(2):426-31. PubMed ID: 20509724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of Upper Blepharoptosis After Cosmetic Botulinum Toxin Type A.
    Steinsapir KD; Groth MJ; Boxrud CA
    Dermatol Surg; 2015 Jul; 41(7):833-40. PubMed ID: 26057409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of brow lifting using botulinum a toxin on upper eyelid height in patients with ptosis undergoing the frontal sling technique.
    Isik D; Tekin H; Karadag R; Bilgili SG; Atik B
    Ann Plast Surg; 2013 Feb; 70(2):175-9. PubMed ID: 22791060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levator aponeurosis dehiscence in a patient treated with botulinum toxin for blepharospasms and eyelid apraxia.
    Verhulst S; Smet H; De Wilde F; Tassignon MJ
    Bull Soc Belge Ophtalmol; 1994; 252():51-3. PubMed ID: 7894756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can ptosis incidence be reduced after lid injections of botulinum A exotoxin for blepharospasm and hemifacial spasm?
    Carruthers J; Carruthers A; Bagaric D
    Can J Ophthalmol; 1995 Apr; 30(3):147. PubMed ID: 7627900
    [No Abstract]   [Full Text] [Related]  

  • 18. Unilateral ptosis: a rare presentation.
    Farooq S; Dukht U; Jaffar S
    J Pak Med Assoc; 2009 May; 59(5):319-21. PubMed ID: 19438140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic ptosis with botulinum toxin in epikeratoplasty.
    Freegard T; Mackie I; Rostron C
    Br J Ophthalmol; 1993 Dec; 77(12):820-2. PubMed ID: 8110683
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the efficacy and safety of botulinum toxin type A to induce temporary ptosis in dogs.
    Bittencourt MK; de Vasconcellos JP; Bittencourt MD; Malagó R; Bacellar M
    J Ocul Pharmacol Ther; 2013 May; 29(4):431-6. PubMed ID: 23323889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.